Filter News
Area of Research
- (-) Fusion and Fission (13)
- (-) Nuclear Science and Technology (9)
- Advanced Manufacturing (9)
- Biology and Environment (27)
- Clean Energy (86)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (2)
- Fusion Energy (2)
- Isotope Development and Production (1)
- Isotopes (16)
- Materials (43)
- Materials for Computing (5)
- National Security (21)
- Neutron Science (17)
- Quantum information Science (2)
- Supercomputing (45)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (2)
- (-) Biomedical (2)
- (-) Computer Science (2)
- (-) Cybersecurity (1)
- (-) Energy Storage (1)
- (-) Fusion (13)
- (-) Isotopes (3)
- (-) Space Exploration (3)
- Advanced Reactors (7)
- Bioenergy (1)
- Biology (1)
- Chemical Sciences (2)
- Decarbonization (2)
- Environment (1)
- Fossil Energy (1)
- Grid (1)
- ITER (3)
- Materials (1)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (3)
- Nuclear Energy (27)
- Partnerships (2)
- Physics (3)
- Security (1)
- Simulation (1)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.